A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components

Cancer is a global health concern and is still the leading cause of death worldwide, with 10 million deaths caused, so far, by the disease in 2020. Although there are treatments to treat some cancers and save lives, these treatments do have drawbacks and can cause side effects. Although various anti...

Full description

Bibliographic Details
Main Authors: Ken H Wong, Darren W Sexton, Alireza Mosavi Jarrahi, Sidgi S Hasson
Format: Article
Language:English
Published: West Asia Organization for Cancer Prevention 2022-12-01
Series:Asian Pacific Journal of Cancer Biology
Subjects:
Online Access:http://www.waocp.com/journal/index.php/apjcb/article/view/968
_version_ 1797338784464896000
author Ken H Wong
Darren W Sexton
Alireza Mosavi Jarrahi
Sidgi S Hasson
author_facet Ken H Wong
Darren W Sexton
Alireza Mosavi Jarrahi
Sidgi S Hasson
author_sort Ken H Wong
collection DOAJ
description Cancer is a global health concern and is still the leading cause of death worldwide, with 10 million deaths caused, so far, by the disease in 2020. Although there are treatments to treat some cancers and save lives, these treatments do have drawbacks and can cause side effects. Although various anticancer remedies have been discovered using natural products in the past, none of them went into clinical trials. Scientists still looking for alternative agents, within animal products. Recently venom is gaining attention for its anticancer activities. Objective: The present study, therefore, aimed to address the theoretical possibility that people bitten by venomous snakes may also develop prophylaxis, i.e., natural immunity, against cancer. And whether snake venom can be used as a vaccine due to their similarities with potential cancer antigens or not. Method: An immunoinformatic analysis was performed by correlating potential snake venom components’ amino sequence data with different cancer antigens. Results: Initially, our findings showed that while developed countries have low snakebite rates, they also demonstrated high cancer rates, in contrast to that developing countries, where they have high snakebite rates but low cancer rates. In terms of the immunoinformatic approach, ten cancer antigens have various similarities with five snake venom components. While the amino acid sequence alignment demonstrates similarities below 40%, the antigenicity index scores were found to be high. We predict that an immune system activated in snakebite victims may elicit an immune response against similar epitopes expressed on cancer cells. Hence, victims of snake bites may gain natural immunity against cancer. Conclusion: This study reports that non-lethal snakebites may play a vital role in protecting individuals from developing cancer in the future. Although it is a pilot study, such a concept and findings will open doors for future work to address this finding.
first_indexed 2024-03-08T09:36:17Z
format Article
id doaj.art-e61f55ad17cc490e9ee2141015273d2b
institution Directory Open Access Journal
issn 2538-4635
language English
last_indexed 2024-03-08T09:36:17Z
publishDate 2022-12-01
publisher West Asia Organization for Cancer Prevention
record_format Article
series Asian Pacific Journal of Cancer Biology
spelling doaj.art-e61f55ad17cc490e9ee2141015273d2b2024-01-30T09:32:07ZengWest Asia Organization for Cancer PreventionAsian Pacific Journal of Cancer Biology2538-46352022-12-017432333910.31557/apjcb.2022.7.4.323-339968A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom ComponentsKen H Wong0Darren W Sexton1Alireza Mosavi Jarrahi2Sidgi S Hasson3Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, UK.Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, UK.Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, UK.Cancer is a global health concern and is still the leading cause of death worldwide, with 10 million deaths caused, so far, by the disease in 2020. Although there are treatments to treat some cancers and save lives, these treatments do have drawbacks and can cause side effects. Although various anticancer remedies have been discovered using natural products in the past, none of them went into clinical trials. Scientists still looking for alternative agents, within animal products. Recently venom is gaining attention for its anticancer activities. Objective: The present study, therefore, aimed to address the theoretical possibility that people bitten by venomous snakes may also develop prophylaxis, i.e., natural immunity, against cancer. And whether snake venom can be used as a vaccine due to their similarities with potential cancer antigens or not. Method: An immunoinformatic analysis was performed by correlating potential snake venom components’ amino sequence data with different cancer antigens. Results: Initially, our findings showed that while developed countries have low snakebite rates, they also demonstrated high cancer rates, in contrast to that developing countries, where they have high snakebite rates but low cancer rates. In terms of the immunoinformatic approach, ten cancer antigens have various similarities with five snake venom components. While the amino acid sequence alignment demonstrates similarities below 40%, the antigenicity index scores were found to be high. We predict that an immune system activated in snakebite victims may elicit an immune response against similar epitopes expressed on cancer cells. Hence, victims of snake bites may gain natural immunity against cancer. Conclusion: This study reports that non-lethal snakebites may play a vital role in protecting individuals from developing cancer in the future. Although it is a pilot study, such a concept and findings will open doors for future work to address this finding.http://www.waocp.com/journal/index.php/apjcb/article/view/968cancer, vaccine, snakebite, prophylaxis
spellingShingle Ken H Wong
Darren W Sexton
Alireza Mosavi Jarrahi
Sidgi S Hasson
A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
Asian Pacific Journal of Cancer Biology
cancer, vaccine, snakebite, prophylaxis
title A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
title_full A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
title_fullStr A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
title_full_unstemmed A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
title_short A Preliminary Investigation on the Possibility of Developing a Cancer Vaccine Using Snake Venom Components
title_sort preliminary investigation on the possibility of developing a cancer vaccine using snake venom components
topic cancer, vaccine, snakebite, prophylaxis
url http://www.waocp.com/journal/index.php/apjcb/article/view/968
work_keys_str_mv AT kenhwong apreliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT darrenwsexton apreliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT alirezamosavijarrahi apreliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT sidgishasson apreliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT kenhwong preliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT darrenwsexton preliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT alirezamosavijarrahi preliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents
AT sidgishasson preliminaryinvestigationonthepossibilityofdevelopingacancervaccineusingsnakevenomcomponents